Results - not time - are how to measure how effective your treatments are. Never base your rates in time.
I would take any mention of time OFF your website. If you want to include wording to the effect that an initial visit may be up to a certain amount of time, that’s one thing. But you aren’t an insurance company and your treatments should not be attached to a pre determined amount of time. That’s setting an expectation that you don’t want the patient to have
I had more happy patients when I spent less time with them but used skills that were much more effective.
Believe me, patients don’t want to be in your clinic for an hour or more. Unless you serve alcohol and food.
Caveat - you don’t need to spend 10 years learning how to be effective and deliver exceptional results. We have the training to get you there much faster.
If you treat patients with plantar fasciitis, this video is worth your time. Anthony breaks it down with key treatment targets you might be missing.
Register for the next EXSTORE course or book a refresher if you need to brush up:
https://aseseminars.com/event/the-exstore-orthopedic-system-for-dry-needlers
Hi all, is there an alternative needle placement for cervical perfusion? I have a patient here today with a spinal cord stimulator with leads at T3 who needs c spine perfusion.
Know anyone curious about treating MSK issues? Invite them!
Tonight’s webinar and live lab are free and open to the public — you just need to register first.
Webinar: 8pm EST
Live Lab: 8:30pm EST
Register Here: https://us02web.zoom.us/meeting/register/cVU76uSoSiy11CJzk4Aq0g
I have a patient, on her 70's, Hx of cancer with chronic knee pain. She states that her knee hurts when she moves. Because of cancer Hx, I am assuming she is considered a chronic systemic patient , correct? She has arthritis on her knee. Do I needle her knee intra-articular with 100 Hx? or 20 hx? Or should I not needle her knee intra-articular?
I am getting a little confused when to use 100hz versus 20 hx in a patient with arthritis and pain in knee.